Propionibacterium species and follicular keratinocyte activation in acneic and normal skin

British Journal of Dermatology

Volumn 172, Issue 4, 2015, Pages 981-987

  Jahns, A C ^a   Eilers, H ^a   Ganceviciene, R ^b   Alexeyev, O A ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b VILNIUS UNIVERSITY   (Lithuania)

Author keywords

[No Author keywords available]

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; CYTOKERATIN 16; KI 67 ANTIGEN; PROTEIN P63; BACTERIUM ANTIBODY;

ACNE VULGARIS; ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM DETECTION; BIOFILM; CELL ACTIVATION; CELL PROLIFERATION; CLINICAL ARTICLE; COHORT ANALYSIS; COMEDO; CONTROLLED STUDY; FEMALE; FLUORESCENCE MICROSCOPY; HAIR FOLLICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCHEMISTRY; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MALE; PRIORITY JOURNAL; PROPIONIBACTERIUM; PROPIONIBACTERIUM ACNES; PROPIONIBACTERIUM AVIDUM; PROPIONIBACTERIUM GRANULOSUM; PROTEIN EXPRESSION; STRATUM CORNEUM; CASE CONTROL STUDY; CHILD; CYTOLOGY; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; SEBUM; SKIN; YOUNG ADULT;

ACNE VULGARIS; ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; CASE-CONTROL STUDIES; CELL PROLIFERATION; CHILD; FEMALE; HUMANS; KERATINOCYTES; MALE; PROPIONIBACTERIUM; SEBUM; SKIN; YOUNG ADULT;

EID: 84943589880     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13436     Document Type: Article

References (48)

1. Zouboulis CC, Eady A, Philpott M, et al,. What is the pathogenesis of acne? Exp Dermatol 2005; 14: 143-52.
2. Dawson AL, Dellavalle RP,. Acne vulgaris. BMJ 2013; 346: f2634.
3. Alestas T, Ganceviciene R, Fimmel S, et al,. Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands. J Mol Med (Berl) 2006; 84: 75-87.
4. Zouboulis CC, Jourdan E, Picardo M,. Acne is an inflammatory disease and alterations of sebum composition initiate acne lesions. J Eur Acad Dermatol Venereol 2014; 28: 527-32.
5. Kurokawa I, Danby FW, Ju Q, et al,. New developments in our understanding of acne pathogenesis and treatment. Exp Dermatol 2009; 18: 821-32.
6. Leyden JJ, McGinley KJ, Vowels B,. Propionibacterium acnes colonization in acne and nonacne. Dermatology 1998; 196: 55-8.
7. Leeming JP, Holland KT, Cunliffe WJ,. The microbial colonization of inflamed acne vulgaris lesions. Br J Dermatol 1988; 118: 203-8.
8. Wollina U, Abdel-Naser MB, Ganceviciene R, et al,. Receptors of eccrine, apocrine, and holocrine skin glands. Dermatol Clin 2007; 25: 577-88.
9. Ganceviciene R, Fimmel S, Glass E, et al,. Psoriasin and follicular hyperkeratinization in acne comedones. Dermatology 2006; 213: 270-2.
10. Ganceviciene R, Graziene V, Böhm M, et al,. Increased in situ expression of melanocortin-1 receptor in sebaceous glands of lesional skin of patients with acne vulgaris. Exp Dermatol 2007; 16: 547-52.
11. Toyoda M, Morohashi M,. Pathogenesis of acne. Med Electron Microsc 2001; 34: 29-40.
12. Kligman AM,. An overview of acne. J Invest Dermatol 1974; 62: 268-87.
13. Knaggs HE, Holland DB, Morris C, et al,. Quantification of cellular proliferation in acne using the monoclonal antibody Ki-67. J Invest Dermatol 1994; 102: 89-92.
14. Aldana OL, Holland DB, Cunliffe WJ,. Variation in pilosebaceous duct keratinocyte proliferation in acne patients. Dermatology 1998; 196: 98-9.
15. Hughes BR, Morris C, Cunliffe WC, et al,. Keratin expression in pilosebaceous epithelia in truncal skin of acne patients. Br J Dermatol 1996; 134: 247-56.
16. Jahns AC, Lundskog B, Ganceviciene R, et al,. An increased incidence of Propionibacterium acnes biofilms in acne vulgaris: a case-control study. Br J Dermatol 2012; 167: 50-8.
17. Shaheen B, Gonzalez M,. A microbial aetiology of acne: what is the evidence? Br J Dermatol 2011; 165: 474-85.
18. Leyden JJ,. The evolving role of Propionibacterium acnes in acne. Semin Cutan Med Surg 2001; 20: 139-43.
19. Isard O, Knol AC, Ariès MF, et al,. Propionibacterium acnes activates the IGF-1/IGF-1R system in the epidermis and induces keratinocyte proliferation. J Invest Dermatol 2011; 131: 59-66.
20. Kistowska M, Gehrke S, Jankovic D, et al,. IL-1β drives inflammatory responses to Propionibacterium acnes in vitro and in vivo. J Invest Dermatol 2014; 134: 677-85.
21. Jeremy AHT, Holland DB, Roberts SG, et al,. Inflammatory events are involved in acne lesion initiation. J Invest Dermatol 2003; 121: 20-7.
22. McDowell A, Gao A, Barnard E, et al,. A novel multilocus sequence typing scheme for the opportunistic pathogen Propionibacterium acnes and characterization of type I cell surface-associated antigens. Microbiology 2011; 157: 1990-2003.
23. Lomholt HB, Kilian M,. Population genetic analysis of Propionibacterium acnes identifies a subpopulation and epidemic clones associated with acne. PLoS ONE 2010; 5: e12277.
24. Fitz-Gibbon S, Tomida S, Chiu BH, et al,. Propionibacterium acnes strain populations in the human skin microbiome associated with acne. J Invest Dermatol 2013; 133: 2152-60.
25. Leyden JJ, McGinley KJ, Mills OH, et al,. Propionibacterium levels in patients with and without acne vulgaris. J Invest Dermatol 1975; 65: 282-4.
26. Marples RR, McGinley KJ, Mills OH,. Microbiology of comedones in acne vulgaris. J Invest Dermatol 1973; 60: 80-3.
27. Gloor M, Franke M,. On the propionibacteria in the pilosebaceous ducts of uninvolved skin of acne patients. Arch Dermatol Res 1978; 262: 125-9.
28. Otberg N, Richter H, Schaefer H, et al,. Variations of hair follicle size and distribution in different body sites. J Invest Dermatol 2004; 122: 14-19.
29. Jahns AC, Oprica C, Vassilaki I, et al,. Simultaneous visualization of Propionibacterium acnes and Propionibacterium granulosum with immunofluorescence and in situ hybridization. Anaerobe 2013; 23: 48-54.
30. Jahns AC, Golovleva I, Palmer RH, et al,. Spatial distribution of bacterial-fungal communities in facial skin. J Dermatol Sci 2013; 70: 71-3.
31. Jahns AC, Lundskog B, Berg J, et al,. Microbiology of folliculitis: a histological study of 39 cases. APMIS 2014; 122: 25-32.
32. Grice AE, Kong HH, Conlan S, et al,. Topographical and temporal diversity of the human skin microbiome. Science 2009; 324: 1190-2.
33. Parsek MR, Singh PK,. Bacterial biofilms: an emerging link to disease pathogenesis. Annu Rev Microbiol 2003; 57: 677-701.
34. Bek-Thomsen M, Lomholt HB, Kilian M,. Acne is not associated with yet-uncultured bacteria. J Clin Microbiol 2008; 46: 3355-60.
35. Nordstrom NK, Noble WC,. Colonization of the axilla by Propionibacterium avidum in relation to age. Appl Environ Microbiol 1984; 47: 1360-2.
36. Grice AE, Segre JA,. The skin microbiome. Nat Rev Microbiol 2011; 9: 244-53.
37. McGinley KJ, Webster GF, Leyden JJ,. Regional variations of cutaneous propionibacteria. Appl Environ Microbiol 1978; 35: 62-6.
38. Nakatsuji T, Chiang H-I, Jiang SB, et al,. The microbiome extends to subepidermal compartments of normal skin. Nat Commun 2013; 4: 1431.
39. Alexeyev OA, Jahns AC,. Sampling and detection of skin Propionibacterium acnes: current status. Anaerobe 2012; 18: 479-83.
40. Whale GA, Sutcliffe IC, Morrisson AR, et al,. Purification and characterisation of lipoglycan macroamphiphiles from Propionibacterium acnes. Antonie Van Leeuwenhoek 2004; 86: 77-85.
41. Reis-Filho JS, Torio B, Albergaria A, et al,. p63 expression in normal skin and usual cutaneous carcinomas. J Cutan Pathol 2002; 29: 517-23.
42. Tsujita-Kyutoku M, Kiuchi K, Danbara N, et al,. p63 expression in normal human epidermis and epidermal appendages and their tumors. J Cutan Pathol 2003; 30: 11-17.
43. Noszczyk BH, Majewski ST,. p63 expression during normal cutaneous wound healing in humans. Plast Reconstr Surg 2001; 108: 1242-7.
44. Parsa R, Yang A, McKeon F, et al,. Association of p63 with proliferative potential in normal and neoplastic human keratinocytes. J Invest Dermatol 1999; 113: 1099-105.
45. Hoetelmans RWM, Prins FA, Cornelese-ten Velde I, et al,. Effects of acetone, methanol, or paraformaldehyde on cellular structure, visualized by reflection contrast microscopy and transmission and scanning electron microscopy. Appl Immunohistochem Mol Morphol 2001; 9: 346-51.
46. Selway JL, Kurczab T, Kealey T, et al,. Toll-like receptor 2 activation and comedogenesis: implications for the pathogenesis of acne. BMC Dermatol 2013; 13: 10.
47. Guy R, Green MR, Kealey T,. Modeling acne in vitro. J Invest Dermatol 1996; 106: 176-82.
48. Downie MM, Sanders DA, Kealey T,. Modelling the remission of individual acne lesions in vitro. Br J Dermatol 2002; 147: 869-78.